William Blair research analyst Jed Dorsheimer was a featured guest on Yahoo! Finance’s Market Domination series, where he discussed the proliferation of AI and its impact on the alternative energy sector.
Equity Research
Jed Dorsheimer Discusses AI, Energy with Yahoo! Finance
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
-
Aardvark Therapeutics, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Aardvark Therapeutics, Inc. (AARD $13.98). Aardvark is advancing ARD-101, an oral therapy that targets bitter taste receptors (TAS2Rs) in the gastrointestinal tract, and ARD-201, a combination of ARD-101 and a DPP-4 inhibitor, for treating Prader-Willi syndrome (PWS) and obesity, respectively.
-
-